Globe Newswire
NEW YORK, Oct. 29, 2026 (GLOBE NEWSWIRE) -- As competition in the global automotive market continues to evolve, automakers are exploring ways to fuse technological innovation and product development with local market needs. Under the theme “Future Travel Starts Now,” the 2026 SOUEAST Global Technology Experience Day recently concluded, showcasing the brand’s hybrid technology, product strength, global presence, and progress in implementing its “Travel+” strategy.... (continue reading...)
FORM 8.5 (EPT/RI)
PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY Rule 8.5 of the Takeover Code (the “Code”)
1. KEY INFORMATION
(a) Name of exempt principal trader:Investec Bank Plc(b) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offereeAdvanced Medical Solutions Group... (continue reading...)TORONTO, Oct. 29, 2026 (GLOBE NEWSWIRE) -- Total Metals Corp. (“Total Metals” or the “Company”) (TSX-V: TT) (OTCQB: TTTMF) (FSE: O4N) is pleased to announce the completion of three high-priority drill holes at its High Lake high-grade gold project in Ontario.
“Completing our first three drill holes into the Purdex Zone marks a strong start to our exploration campaign at High Lake,” said Michael Dehn, Executive Chairman for Total Metals Corp. “With RC drilling... (continue reading...)
OMA SAVINGS BANK PLC, INVESTOR NEWS 29.10.2026
Oma Savings Bank Plc to publish its Interim Report for January-September 2026 on 5 November 2026
Oma Savings Bank Plc will publish its Interim Report for January-September 2026 on 5 November 2026. The announcement will be available on the company's website after publication at https://www.omasp.fi/en/investors
Oma Savings Bank Plc
Additional information and Interview requests :Pirjetta Soikkeli, CCO, tel. +358 40 750... (continue reading...)
Positive Phase 2 ACUITY trial findings support Privosegtor’s potential to deliver a first-in-class neuroprotective treatment for patients with optic neuritis and beyond
ZUG, Switzerland, October 29th, 2026 -- Oculis Holding AG (Nasdaq: OCS; XICE: OCS) (“Oculis”), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced upcoming presentations highlighting... (continue reading...)
More Globe Newswire
View Older Stories-
Pacera launches Pacera Lease by AARO in the UK, bringing more than 30 years of AARO accounting heritage to FRS 102 lease reporting.
-
Madronus and NPHS Launch Wildfire Resilience Loans to Help California Homeowners Access Insurance and Reduce Costs
-
IPQS Says Agent Authorization Alone Won’t Secure Agentic Commerce
-
TRG Screen brings terminal usage into focus with Activity Monitor
-
Share Buyback Transaction Details October 22 – October 28, 2026
-
Philips launches UniGuide 3D Live Guidance, bringing CT planning into live procedures and extending the capabilities of its Azurion image-guided therapy platform
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Interim report for the period 1 January - 30 September 2026
-
Uzbek and U.S. Scientists Honored with the 10th World Agriculture Prize
-
HKEX Launches AI Index,Southern Asset Management Authorized to Launch ETF
-
Exogenus Therapeutics leads a €13 million EU-funded consortium to advance a new secretome-based therapy for osteoarthritis
-
ALLOX closes $10.5M seed financing and appoints Morten Graugaard as Chair to scale allosteric drug discovery platform and build pipeline
-
International Petroleum Corporation to release Third Quarter 2026 Financial and Operational Results on November 3, 2026
-
Festi hf.: Presentation of Q3 2026 results
-
International Petroleum Corporation to release Third Quarter 2026 Financial and Operational Results on November 3, 2026
-
THEON moves to completes MERIO acquisition following receipt of required approvals; new orders already awarded
-
LBank to Launch Pre-IPO Market With Kalshi Tokenized Asset Offering
-
Coloplast opens new factory in Portugal to support global growth
-
VirTra Sets Third Quarter 2026 Conference Call for Thursday, November 12, 2026 at 4:30 p.m. ET
-
At Brooklyn AI-Native 6G Summit, InterDigital Champions Wireless Research in the Age of AI
-
STARTRADER Begins Second Season as Official Partner of the NBA
-
Keeping Classics Alive and Evolving: 2026 iCAUR International User Summit Concludes with New Advances in Future Classic Design and Customization Ecosystem
-
Kalmar to supply Tropical Shipping with straddle carrier and reachstacker
-
Syensqo 2027 Financial Calendar
-
Kalmar secures a significant order from the Port of Virginia for Electric Straddle Carriers
-
Increase in the price of the simplified tender offer for North Atlantic Energies shares
-
Michelin: Disclosure of trading in own shares - 29 OCTO 2026
-
Inside information: Kalmar updates its strategy and sets new performance targets for 2030 including a renewed framework for the capital allocation
-
Driving the Future Through Technology: Inside the 2026 SOUEAST Global Technology Experience Day
-
TME Pharma Signs Binding Exclusive Negotiation Agreement with Japanese TMS Co., Ltd.
-
SHELL PLC 2027 INTERIM DIVIDEND TIMETABLE
-
Shell announces commencement of a share buyback programme
-
Shell announces commencement of a share buyback programme
-
Shell plc Third Quarter 2026 Interim Dividend
-
Regarding the election of the Chairman of the Board of LITGRID AB
-
Shell plc publishes third quarter 2026 press release
-
Kalmar's interim report January–September 2026: Resilient third quarter with strong orders and robust cash generation
-
SHELL PLC 3rd QUARTER 2026 AND NINE MONTHS UNAUDITED RESULTS
-
Regarding the election of the Chairman of the Board of LITGRID AB
-
Vaisala completes acquisition of AI weather company Atmo, Inc.
-
Harvia’s Interim report 1 January – 30 September 2026
-
Q3 2026 Trading Update
-
NBPE Announces Transaction in Own Shares
-
INTERIM REPORT FOR THE THIRD QUARTER OF 2026 (UNAUDITED)
-
Transaction in Own Shares
-
Vistin Pharma ASA (VISTN): Key information relating to the cash dividend
-
Vistin Pharma ASA: Third quarter and YTD 2026 financial results
-
Change to the Executive Management of Netcompany Group A/S
-
Solid customer activity, broad-based growth and strong credit quality drove strong results for the first nine months of 2026. Net profit of DKK 18.3 bn. Outlook for the full year 2026 narrowed to a ne
-
Eramet: solid operational momentum in Q3 and progress on the funding plan


